The Union Health Ministry has approved the fixed-dose combination (FDC) of Tamsulosin HCI and Deflazacort for asthma therapy through a gazetted notification.
The notification said that the fixed-dose combination of Tamsulosin HCI 0.4 mg and Deflazacort 30mg in hard gelatine capsule will be withdrawn from the list of medicines that are banned for manufacture and sale.
